Smurfit Westrock (NYSE: SW) Q1 2026 earnings drop as costs surge
Smurfit Westrock delivered modestly higher net sales but sharply lower profit for the three months ended March 31, 2026. Net sales edged up to $7,712 million from $7,656 million, mainly from a positive foreign currency impact that offset weaker volumes.
Net income attributable to common shareholders fell to $65 million from $384 million, and diluted EPS declined to $0.12 from $0.73. Management cites higher cost of goods sold driven by economic downtime, $70 million of accelerated depreciation tied to machine closures, adverse weather impacts of $65 million and higher freight costs, partly offset by lower volumes. Adjusted EBITDA declined to $1,076 million from $1,252 million.
Operating cash flow decreased to $204 million from $235 million, while the company stepped up capital expenditures to $624 million. Total debt rose to $14,255 million, but available liquidity remained sizable at $5,337 million, including $674 million of cash. The board approved a quarterly dividend of $0.4523 per share, payable in June 2026.
Positive
- None.
Negative
- None.
Insights
Higher costs and heavy capex drove a sharp earnings drop despite flat sales.
Smurfit Westrock showed stable demand but weaker profitability. Net sales were broadly flat at $7,712 million, yet net income dropped to $65 million as cost of goods sold rose by $365 million, squeezing margins and cutting EPS to $0.12.
Key cost drivers were economic downtime, adverse weather and freight, plus $70 million of accelerated depreciation from machine closures and higher impairment and restructuring charges. Adjusted EBITDA declined to $1,076 million, indicating pressure on underlying earnings even after excluding one‑off items.
Cash generation softened, with operating cash flow at $204 million while capital expenditures reached $624 million, funded partly by higher debt, which increased to $14,255 million. However, liquidity of $5,337 million and a maintained quarterly dividend of $0.4523 per share suggest the company still has financial flexibility heading into the rest of 2026.
Key Figures
Key Terms
Adjusted EBITDA financial
economic downtime financial
receivables securitization facilities financial
accounts receivable monetization agreements financial
supplier finance programs financial
Variable Interest Entities financial
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
N/A | ||
(Address of principal executive offices) | (Zip Code) |
Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered | ||
☒ | Accelerated filer | ☐ | |
Non-accelerated filer | ☐ | Smaller reporting company | |
Emerging growth company | |||
Page | ||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 3 | |
PART I | FINANCIAL INFORMATION | 5 |
Item 1. | Financial Statements | 5 |
Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and March 31, 2025 | 5 | |
Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2026 and March 31, 2025 | 6 | |
Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025 | 7 | |
Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and March 31, 2025 | 8 | |
Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2026 and March 31, 2025 | 9 | |
Notes to Condensed Consolidated Financial Statements | 11 | |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25 |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 36 |
Item 4. | Controls and Procedures | 36 |
PART II | OTHER INFORMATION | 37 |
Item 1. | Legal Proceedings | 37 |
Item 1A. | Risk Factors | 37 |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 37 |
Item 3. | Defaults Upon Senior Securities | 37 |
Item 4. | Mine Safety Disclosures | 37 |
Item 5. | Other Information | 37 |
Item 6. | Exhibits | 38 |
Signatures | 39 |
Three months ended March 31, | |||
2026 | 2025 | ||
Net sales | $ | $ | |
Cost of goods sold | ( | ( | |
Gross profit | |||
Selling, general and administrative expenses | ( | ( | |
Impairment and restructuring costs | ( | ( | |
Transaction and integration-related expenses associated with the Combination | ( | ||
Operating profit | |||
Interest expense, net | ( | ( | |
Pension and other postretirement non-service income, net | |||
Other expense, net | ( | ( | |
Income before income taxes | |||
Income tax expense | ( | ( | |
Net income | |||
Net loss attributable to noncontrolling interests | |||
Net income attributable to common shareholders | $ | $ | |
Basic earnings per share attributable to common shareholders | $ | $ | |
Diluted earnings per share attributable to common shareholders | $ | $ | |
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||
Three months ended March 31, | |||
2026 | 2025 | ||
Net income | $ | $ | |
Other comprehensive (loss) income, net of tax: | |||
Foreign currency translation (loss) gain | ( | ||
Defined benefit pension and other postretirement benefit plans | ( | ||
Net gain on cash flow hedges | |||
Other comprehensive (loss) income, net of tax | ( | ||
Comprehensive income | |||
Comprehensive loss attributable to noncontrolling interests | |||
Comprehensive income attributable to common shareholders | $ | $ | |
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Financial Statements. | |||
March 31, 2026 | December 31, 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents (amounts related to consolidated variable interest entities of $ $ | $ | $ | |
Accounts receivable, net (amounts related to consolidated variable interest entities of $ $ | |||
Inventories | |||
Other current assets | |||
Total current assets | |||
Property, plant and equipment, net | |||
Goodwill | |||
Intangibles, net | |||
Prepaid pension asset | |||
Other non-current assets (amounts related to consolidated variable interest entities of $ $ | |||
Total assets | $ | $ | |
Liabilities and Equity | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Accrued expenses | |||
Accrued compensation and benefits | |||
Current portion of debt | |||
Other current liabilities | |||
Total current liabilities | |||
Non-current debt due after one year (amounts related to consolidated variable interest entities of $ | |||
Deferred tax liabilities | |||
Pension liabilities and other postretirement benefits, net of current portion | |||
Other non-current liabilities (amounts related to consolidated variable interest entities of $ and $ | |||
Total liabilities | |||
Commitments and Contingencies (Note 13) | |||
Equity: | |||
Preferred stock, $ | |||
Common stock, $ shares outstanding at March 31, 2026 and December 31, 2025, respectively | |||
Treasury stock, at cost; 2025, respectively | ( | ( | |
Capital in excess of par value | |||
Accumulated other comprehensive loss | ( | ( | |
Retained earnings | |||
Total shareholders’ equity | |||
Noncontrolling interests | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three months ended March 31, | |||
2026 | 2025 | ||
Operating activities: | |||
Net income | $ | $ | |
Adjustments to reconcile consolidated net income to net cash provided by operating activities: | |||
Depreciation, depletion and amortization | |||
Impairment of assets | |||
Cash surrender value increase in excess of premiums paid | ( | ( | |
Share-based compensation expense | |||
Deferred income tax benefit | ( | ( | |
Pension and other postretirement funding more than cost | ( | ( | |
Other | ( | ||
Change in operating assets and liabilities, net of acquisitions and divestitures: | |||
Accounts receivable | ( | ( | |
Inventories | ( | ||
Other assets | ( | ( | |
Accounts payable | ( | ( | |
Income taxes | ( | ( | |
Accrued liabilities and other | ( | ( | |
Net cash provided by operating activities | |||
Investing activities: | |||
Capital expenditures | ( | ( | |
Cash paid for purchase of businesses, net of cash acquired | ( | ( | |
Proceeds from corporate owned life insurance | |||
Proceeds from sale of property, plant and equipment | |||
Other | |||
Net cash used for investing activities | ( | ( | |
Financing activities: | |||
Additions to debt | |||
Repayments of debt | ( | ( | |
Debt issuance costs | ( | ( | |
Changes in commercial paper, net | |||
Other debt additions (repayments), net | ( | ||
Repayments of finance lease liabilities | ( | ( | |
Proceeds from re-issuance of shares from treasury stock | |||
Tax paid in connection with shares withheld from employees | ( | ( | |
Cash dividends paid to shareholders | ( | ( | |
Other | |||
Net cash provided by financing activities | |||
Effect of exchange rate changes on cash and cash equivalents | ( | ||
Decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at beginning of period | |||
Cash and cash equivalents at end of period | $ | $ | |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive loss, net of tax | — | — | — | — | — | ( | ( | — | ( |
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust, net of tax paid in connection with shares withheld from employees | — | — | ( | ( | — | ( | — | ( | |
Re-issuance of shares by Smurfit Kappa Employee Trust | — | — | — | — | — | ||||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at March 31, 2026 | $ | $ | $( | $ | $( | $ | $ | $ |
Shares of Common Stock | Common Stock | Capital in Excess of Par Value | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Loss | Total Shareholders' Equity | Noncontrolling Interest | Total | |
Balance at December 31, 2024 | $ | $ | $( | $ | $( | $ | $ | $ | |
Net income | — | — | — | — | — | ( | |||
Other comprehensive income, net of tax | — | — | — | — | — | — | |||
Share-based compensation | — | — | — | — | — | — | |||
Shares distributed by Smurfit Kappa Employee Trust | — | — | ( | — | — | — | |||
Issuance of common stock net of tax paid in connection with shares withheld from employees | — | — | ( | — | ( | — | ( | ||
Cancellation of shares held in treasury stock by Smurfit Kappa Employee Trust | — | — | — | ( | — | — | |||
Dividends declared ($ | — | — | — | ( | — | ( | — | ( | |
Balance at March 31, 2025 | $ | $ | $( | $ | $( | $ | $ | $ |
Three months ended March 31, 2026 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended March 31, 2025 | North America | Europe, MEA and APAC | LATAM | Total | |||
Net sales (unaffiliated customers) | $ | $ | $ | $ | |||
Add net sales (intersegment) | |||||||
Net sales (aggregate) | |||||||
Less segment expenses: | |||||||
Segment cost of goods sold | ( | ( | ( | ||||
Segment selling, general and administrative expenses | ( | ( | ( | ||||
( | ( | ( | ( | ||||
Segment Adjusted EBITDA | $ | $ | $ | $ | |||
Unallocated corporate costs | ( | ||||||
Depreciation, depletion and amortization | ( | ||||||
Impairment and restructuring costs | ( | ||||||
Transaction and integration-related expenses associated with the Combination | ( | ||||||
Interest expense, net | ( | ||||||
Pension and other postretirement non-service income, net | |||||||
Share-based compensation expense | ( | ||||||
Other expense, net | ( | ||||||
Other adjustments | ( | ||||||
Income before income taxes | $ |
Three months ended March 31, | |||
2026 | 2025 | ||
Capital expenditures: | |||
North America | $ | $ | |
Europe, MEA and APAC | |||
LATAM | |||
Total per reportable segments | |||
Corporate | |||
Total capital expenditures | $ | $ | |
Three months ended March 31, 2026 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
Three months ended March 31, 2025 | |||||||
North America | Europe, MEA and APAC | LATAM | Total | ||||
Revenue by product: | |||||||
Paper | $ | $ | $ | $ | |||
Packaging | |||||||
Total | $ | $ | $ | $ | |||
March 31, | December 31, | ||
2026 | 2025 | ||
Gross accounts receivable | $ | $ | |
Less: Allowances | ( | ( | |
Accounts receivable | $ | $ |
March 31, | December 31, | ||
2026 | 2025 | ||
Finished goods | $ | $ | |
Work-in-progress | |||
Raw materials | |||
Consumables and spare parts | |||
Inventories | $ | $ |
March 31, | December 31, | ||
2026 | 2025 | ||
Land and buildings | $ | $ | |
Plant and equipment | |||
Construction-in-progress | |||
Finance lease right-of-use assets | |||
Property, plant and equipment at cost, excluding forestlands | |||
Less: Accumulated depreciation and impairment | ( | ( | |
Property, plant and equipment, net, excluding forestlands | |||
Forestlands, net of depletion | |||
Property, plant and equipment, net | $ | $ |
Three months ended March 31, | |||
2026 | 2025 | ||
Interest expense | $( | $( | |
Interest income | |||
Interest expense, net | $( | $( | |
March 31, 2026 | December 31, 2025 | ||||||
Book Value | Fair Value | Book Value | Fair Value | ||||
Debt with fixed interest rates | $ | $ | $ | $ | |||
Three months ended March 31, | |||
2026 | 2025 | ||
Receivable from financial institutions at January 1 | $ | $ | |
Receivables sold to the financial institutions and derecognized | ( | ( | |
Receivables collected by financial institutions | |||
Cash payments to financial institutions | ( | ( | |
Receivable from financial institutions at March 31 | $ | $ | |
March 31, | December 31, | ||
2026 | 2025 | ||
$ | $ | $ | |
$ | |||
$ | |||
$ | |||
€ | |||
€ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
€ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
€ | |||
$ | |||
$ | |||
$ | |||
Commercial paper | |||
Vendor financing and commercial card programs | |||
Farm credit facility | |||
Other bank loans | |||
Finance lease obligations | |||
Total debt, excluding fair value adjustments, bond discounts and debt issuance costs | |||
Unamortized fair value adjustments, bond discounts and debt issuance costs | ( | ( | |
Total debt | |||
Less: Current portion of debt | ( | ( | |
Non-current debt due after one year | $ | $ |
Defined Benefit Pension Plans | |||||||
U.S. Plans | Non-U.S. Plans | ||||||
Three months ended March 31, | |||||||
2026 | 2025 | 2026 | 2025 | ||||
Service cost | $ | $ | $ | $ | |||
Interest cost | |||||||
Expected return on assets | ( | ( | ( | ( | |||
Amortization of: | |||||||
Net actuarial loss | |||||||
Prior service credit | ( | ||||||
Net periodic benefit (income) cost | $( | $( | $ | $ | |||
Three months ended March 31, | |||
2026 | 2025 | ||
Numerator: | |||
Net income attributable to common shareholders | $ | $ | |
Denominator: | |||
Basic weighted average shares outstanding | |||
Effect of dilutive share options | |||
Diluted weighted average shares outstanding | |||
Basic earnings per share attributable to common shareholders | $ | $ | |
Diluted earnings per share attributable to common shareholders | $ | $ | |
March 31, | December 31, | ||
2026 | 2025 | ||
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ | $ | |
Accounts receivable | |||
Inventories | |||
Other current assets | |||
Non-current assets: | |||
Property, plant and equipment, net | |||
Other non-current assets | |||
Total assets | $ | $ | |
Liabilities | |||
Current liabilities: | |||
Accounts payable | $ | $ | |
Current portion of debt | |||
Other current liabilities | |||
Non-current liabilities: | |||
Non-current debt due after one year | |||
Other non-current liabilities | |||
Total liabilities | $ | $ |
Foreign Currency Translation | Cash Flow Hedges | Defined Benefit Pension and Other Postretirement Benefit Plans | Other Adjustments(1) | Total (2) | |
Balance at December 31, 2024 | $ | $ | $ | $( | $ |
Other comprehensive (income) loss | ( | ( | ( | ||
Balance at March 31, 2025 | $ | $ | $ | $( | $ |
Balance at December 31, 2025 | $ | $ | $ | $( | $ |
Other comprehensive loss (income) | ( | ( | |||
Balance at March 31, 2026 | $ | $ | $ | $( | $ |
Three months ended March 31, | |||||||
2026 | 2025 | ||||||
Pre-Tax | Tax | Net of Tax | Pre-Tax | Tax | Net of Tax | ||
Foreign currency translation (loss) gain | $( | $ | $( | $ | $ | $ | |
Defined benefit pension and other postretirement benefit plans: | |||||||
Amortization and settlement recognition of net actuarial loss | ( | ||||||
Amortization of prior service credit | ( | ( | |||||
Foreign currency gain (loss) - pensions | ( | ( | |||||
Changes in fair value of cash flow hedges | |||||||
Consolidated other comprehensive (loss) income | ( | ( | ( | ||||
Other comprehensive loss (income) attributable to noncontrolling interests | |||||||
Other comprehensive (loss) income attributable to common shareholders | $( | $( | $( | $ | $ | $ | |
Three months ended March 31, | ||||
2026 | 2025 | |||
Net sales | $7,712 | $7,656 | ||
Cost of goods sold | (6,444) | (6,079) | ||
Gross profit | 1,268 | 1,577 | ||
Selling, general and administrative expenses | (961) | (973) | ||
Impairment and restructuring costs | (54) | (15) | ||
Transaction and integration-related expenses associated with the Combination | — | (36) | ||
Operating profit | 253 | 553 | ||
Interest expense, net | (166) | (167) | ||
Pension and other postretirement non-service income, net | 8 | 9 | ||
Other expense, net | (11) | (5) | ||
Income before income taxes | 84 | 390 | ||
Income tax expense | (21) | (8) | ||
Net income | 63 | 382 | ||
Net loss attributable to noncontrolling interests | 2 | 2 | ||
Net income attributable to common shareholders | $65 | $384 | ||
Three months ended March 31, | ||||
2026 | 2025 | |||
Net sales (aggregate):(1) | ||||
North America | $4,502 | $4,669 | ||
Europe, MEA and APAC | 2,771 | 2,582 | ||
LATAM | 540 | 513 | ||
Segment Adjusted EBITDA: | ||||
North America | $597 | $785 | ||
Europe, MEA and APAC | 421 | 389 | ||
LATAM | 109 | 115 | ||
Three months ended March 31, | |||
2026 | 2025 | ||
Net cash provided by operating activities | $204 | $235 | |
Net cash used for investing activities | $(627) | $(476) | |
Net cash provided by financing activities | $209 | $151 | |
Three months ended March 31, | ||||
2026 | 2025 | |||
Net income | $63 | $382 | ||
Income tax expense | 21 | 8 | ||
Depreciation, depletion and amortization | 728 | 603 | ||
Impairment and restructuring costs | 54 | 15 | ||
Transaction and integration-related expenses associated with the Combination | — | 36 | ||
Interest expense, net | 166 | 167 | ||
Pension and other postretirement non-service income, net | (8) | (9) | ||
Share-based compensation expense | 28 | 43 | ||
Other expense, net | 11 | 5 | ||
Other adjustments | 13 | 2 | ||
Adjusted EBITDA | $1,076 | $1,252 | ||
SUMMARIZED STATEMENT OF OPERATIONS | Three months ended March 31, |
2026 | |
Net sales to unrelated parties | $355 |
Net sales to Non-Obligor Subsidiaries | 305 |
Gross profit | 151 |
Interest expense, net with unrelated parties | (152) |
Interest expense, net with Non-Obligor Subsidiaries | (79) |
Net income and net income attributable to the Obligor Group | 527 |
SUMMARIZED BALANCE SHEETS | March 31, | December 31, | |
2026 | 2025 | ||
ASSETS | |||
Current amounts due from Non-Obligor Subsidiaries | $4,631 | $4,571 | |
Other current assets | 955 | 1,207 | |
Total current assets | $5,586 | $5,778 | |
Non-current amounts due from Non-Obligor Subsidiaries | $3,330 | $3,355 | |
Other non-current assets | 932 | 918 | |
Total non-current assets | $4,262 | $4,273 | |
LIABILITIES | |||
Current amounts due to Non-Obligor Subsidiaries | $8,305 | $9,130 | |
Other current liabilities | 1,039 | 482 | |
Total current liabilities | $9,344 | $9,612 | |
Non-current amounts due to Non-Obligor Subsidiaries | $7,380 | $7,447 | |
Other non-current liabilities | 11,682 | 11,823 | |
Total non-current liabilities | $19,062 | $19,270 |
Period | Total Number of Shares Purchased(1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||
January 1, 2026 – January 31, 2026 | — | $— | — | — | |||
February 1, 2026 – February 28, 2026 | 21,252 | 51.42 | — | — | |||
March 1, 2026 – March 31, 2026 | — | — | — | — | |||
Total | 21,252 | — |
Exhibit Number | Description of Exhibit | ||
3.1 | Amended Constitution of Smurfit Westrock plc (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed on July 8, 2024). | ||
22 | List of Guarantor Subsidiaries and Issuers of Guaranteed Securities (incorporated by reference to Exhibit 22 of the Company’s Annual Report on Form 10-K filed on February 27, 2026). | ||
31.1† | Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2† | Certification of the Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32†* | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.** | ||
101.SCH | Inline XBRL Taxonomy Extension Schema.** | ||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase.** | ||
101.DEF | Inline XBRL Taxonomy Extension Definition Document.** | ||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase.** | ||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase.** | ||
104 | Cover Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
Smurfit Westrock plc | ||
Dated: May 1, 2026 | /s/ Anthony Smurfit | |
Name: | Anthony Smurfit | |
Title: | President & Group Chief Executive Officer | |
(Principal Executive Officer) | ||
Smurfit Westrock plc | ||
Dated: May 1, 2026 | /s/ Ken Bowles | |
Name: | Ken Bowles | |
Title: | Executive Vice President & Group Chief Financial Officer | |
(Principal Financial Officer) | ||